Burlington peripheral vascular device maker discontinues its employee stock purchase plan, effective July 31. - 15 July 2009

LeMaitre Vascular Inc.'s
board of directors decided to spike the Burlington peripheral vascular
device maker's employee stock purchasing plan, effective July 31,
according to a filing with the federal Securities and Exchange Commission.

Under the terms of the plan, employees can buy stock in the company
for 90 percent of its fair-market value and can elect to put up to 10
percent of their pay toward purchasing shares.

LeMaitre CFO J.J. Pellegrino did not immediately return a call for comment.